Get the latest tech news
Early cancer detection startup Craif raises $22M
Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million
Craif, spun off from Nagoya University in Japan in 2018, is using microRNA(miRNA) to develop an AI-powered early cancer detection software, and it has raised $22 million in Series C funding to expand further into the U.S. market and bolster its R&D. Early detection of a treatable condition can be challenging as traditional diagnostic methods like blood tests can be invasive, causing some people to avoid regular screening, Onose said. Craif’s first product, miSignal, a test that detects the risk of seven different cancers (pancreatic, colorectal, lung, stomach, esophagus breast, ovarian) using urinary miRNA, is already generating revenues in Japan.
Or read this on TechCrunch